Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation. The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions.

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore blind people's sight.

Elon Musk has announced that his company Neuralink has received approval for a brain implant called "Blindsight" that will enable the blind to see again.

Elon Musk's brain-chip startup has just received its first big win, the breakthrough device, experimental implant, Blindsight got approval from the US Food and

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

Elon Musk's Neuralink has received FDA approval for its vision-restoring implant, Blindsight. This breakthrough device aims to help people who have lost their vision or were born blind. It works by directly stimulating the visual cortex,

Elon Musk's Neuralink has introduced Blindsight which will provide sight to those who are blind from birth through an experimental vision-restoring implant